ATE353886T1 - Verbindungen und verfahren zur behandlung einer hyperaktiven blase - Google Patents

Verbindungen und verfahren zur behandlung einer hyperaktiven blase

Info

Publication number
ATE353886T1
ATE353886T1 AT02783904T AT02783904T ATE353886T1 AT E353886 T1 ATE353886 T1 AT E353886T1 AT 02783904 T AT02783904 T AT 02783904T AT 02783904 T AT02783904 T AT 02783904T AT E353886 T1 ATE353886 T1 AT E353886T1
Authority
AT
Austria
Prior art keywords
compounds
sup
methods
hyperactive bladder
disclosed
Prior art date
Application number
AT02783904T
Other languages
English (en)
Inventor
Russell Bialecki
Cathy Dantzman
Keith Herzog
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE353886T1 publication Critical patent/ATE353886T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT02783904T 2001-11-02 2002-11-01 Verbindungen und verfahren zur behandlung einer hyperaktiven blase ATE353886T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103795A SE0103795D0 (sv) 2001-11-02 2001-11-02 Compounds and method for the treatment of överactive bladder

Publications (1)

Publication Number Publication Date
ATE353886T1 true ATE353886T1 (de) 2007-03-15

Family

ID=20285984

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02783904T ATE353886T1 (de) 2001-11-02 2002-11-01 Verbindungen und verfahren zur behandlung einer hyperaktiven blase

Country Status (16)

Country Link
US (1) US7368461B2 (de)
EP (1) EP1444220B1 (de)
JP (1) JP2005511571A (de)
KR (1) KR20040053239A (de)
CN (1) CN1610676A (de)
AT (1) ATE353886T1 (de)
BR (1) BR0213832A (de)
CA (1) CA2465429A1 (de)
DE (1) DE60218203T2 (de)
ES (1) ES2282491T3 (de)
IL (1) IL161600A0 (de)
MX (1) MXPA04004075A (de)
NO (1) NO20042138L (de)
SE (1) SE0103795D0 (de)
WO (1) WO2003037889A1 (de)
ZA (1) ZA200403206B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200508221A (en) 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
DE102004001873A1 (de) * 2004-01-14 2005-09-29 Bayer Healthcare Ag Cyanopyrimidinone
WO2006121389A1 (en) * 2005-05-10 2006-11-16 Astrazeneca Ab Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity
AR057828A1 (es) 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
US8106208B2 (en) 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
TWI404721B (zh) 2009-01-26 2013-08-11 Pfizer 胺基－雜環化合物
CN112915266B (zh) * 2021-02-05 2021-11-09 武汉磁济科技有限公司 一种人工膀胱铁磁复合体及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321557D0 (en) * 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
GB9310713D0 (en) 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
GB9322643D0 (en) * 1993-11-03 1993-12-22 Zeneca Ltd Lactam derivatives
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9421709D0 (en) * 1994-10-27 1994-12-14 Zeneca Ltd Therapeutic compounds
GB9505084D0 (en) * 1995-03-14 1995-05-03 Pfizer Ltd Benzamide derivative
GB9922519D0 (en) 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
AU3061499A (en) * 1998-12-04 2000-06-26 Rimma Iliinichna Ashkinazi Aryl- and heteroarylamides of carboalkoxysulfanilic acids
GB9826941D0 (en) 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence

Also Published As

Publication number Publication date
IL161600A0 (en) 2004-09-27
EP1444220A1 (de) 2004-08-11
EP1444220B1 (de) 2007-02-14
WO2003037889A1 (en) 2003-05-08
DE60218203T2 (de) 2008-01-03
KR20040053239A (ko) 2004-06-23
NO20042138L (no) 2004-05-25
CN1610676A (zh) 2005-04-27
US7368461B2 (en) 2008-05-06
ES2282491T3 (es) 2007-10-16
SE0103795D0 (sv) 2001-11-02
US20050203113A1 (en) 2005-09-15
WO2003037889A8 (en) 2004-05-06
CA2465429A1 (en) 2003-05-08
BR0213832A (pt) 2004-08-31
DE60218203D1 (de) 2007-03-29
JP2005511571A (ja) 2005-04-28
MXPA04004075A (es) 2004-07-23
ZA200403206B (en) 2005-02-22

Similar Documents

Publication Publication Date Title
HK1068136A1 (en) Muscarinic antagonists
ATE334985T1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
CY1110742T1 (el) Αναστολεις ινδαζολης, βενζισοξαζολης, και βενζισοθειαζολης
ATE320803T1 (de) Verfahren zur behandlung von alzheimerschen krankheit
DK0842934T3 (da) 5-HT1F agonister
DE60043308D1 (de) Verfahren zur behandlung der schädigung des zentralnervensystems durch ischämie oder durch hämorrhagie mit antagonisten von alpha4 integrin
ATE460413T1 (de) Substituierte 1-propinoyl-piperazine mit affinität für den mglur5 rezeptor zur behandlung von schmerzzuständen
DE602006019754D1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
ATE357917T1 (de) Behandlung von dyskinesie durch mu-selektive opioidantagonisten
TW200502234A (en) Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
ATE353886T1 (de) Verbindungen und verfahren zur behandlung einer hyperaktiven blase
SE0003476D0 (sv) Compounds
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
BR0112122A (pt) Composto de rutênio (ii) , uso de um composto, composição farmacêutica, método para tratar e/ou prevenir o câncer, e, processo para preparar um composto
NO20002408D0 (no) 5-HT1F antagonister
ATE326223T1 (de) Methode zur behandlung der hyperaktiven blase
ATE252589T1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
ATE451367T1 (de) Verfahren zur herstellung von ziprasidon
GB0223223D0 (en) Organic compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties